Efficacy an Safety of Volinanserin on Sleep Maintenance Insomnia With a Sub-study on Stable Type II Diabetes Mellitus

NCT00464061 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

1847

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor's decision due to absence of demonstration of efficacy of volinanserin in primary insomnia with predominant sleep maintenance problems

Conditions

Sleep Initiation and Maintenance Disorders

Interventions

DRUG: Volinanserin
DRUG: Placebo

Sponsor

Sanofi